1Yalaz M,Cetin H,Akisu M,et al.Neonatal nosocomial sepsis in a level-III NICU:evaluation of the causative agents and antimicrobial susceptibilities[J].Turk J Pediatr,2006,48(1):13-18.
2Kollef MH.The intensive care unit as a research laboratory:developing strategies to prevent antimicrobial resistance[J].Surg Infect(Larchmt),2006,7(2):85-99.
3Temple ME,Jakubecz MA,Link NA.Implementation of a training program to improve pharmacy services for highrisk neonatal and maternal populations[J].Am J Health Syst Pharm,2013,70(2):144-149.
4Standing JF,Nika A,Tsagris V,et al.Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unit[J].Antimicrob Agents Chemother,2012,56(7):3833-3840.
5Helder O,Van Den Hoogen A,De Boer C,et al.Effectiveness of non-pharmacological interventions for the prevention of bloodstream infections in infants admitted to a neonatal intensive care unit:A systematic review[J].Int J Nurs Stud,2013,50(6):819-831.
